Industry Insights
Moderna's COVID-19 Vaccine Shows Positive Interim Results in Phase I Trial
Industry InsightOne of the COVID-19 vaccine candidates that received fast track designation by the FDA is mRNA-1273, developed by Moderna, a clinical stage biotechnology company. The company has shared the positive interim results from a Phase I clinical trial of the vaccine in The New England Journal of Medicine .
Read More
Driving Speed, Sensitivity and Precision in Modern Proteomics
Industry InsightTechnology Networks spoke with Rohan Thakur, Executive Vice President of Life Sciences Mass Spectrometry at Bruker Daltonics, to discuss the company's latest analytical technologies and their capabilities.
Read More
Taking a Closer Look at Trends in Microscopy
Industry InsightWith advances in cellular and tissue-based imaging, researchers are able to peel back the layers on new challenges and test hypotheses to solve more problems. We heard about some of the advancements being made in the field of confocal microscopy.
Read More
Ramping Up Drug, Vaccine and Infectivity Testing With Airway Organoids
Industry InsightIn this article, we take a closer look at the use of lung and airway organoids for drug and vaccine development and explore how they are being used to study infectivity in human respiratory diseases, such as COVID-19.
Read More
Improving Gene Editing by Promoting Error-free Repair of CRISPR/Cas9-cut DNA
Industry InsightWith the first clinical trial of CRISPR gene editing in progress and the controversy of the first gene-edited babies continuing to spark discussion, it is more important than ever to better understand not only the benefits but also the risks of CRISPR-based therapies.
Read More
Three Definitely Isn't a Crowd When It Comes to Protein Complex Analysis
Industry InsightIn a study published in Cell Reports, members of the Washburn Lab described their three-pronged approach to analyzing protein complexes – affinity tag protein purification, chemical crosslinking with high-resolution mass spectrometry and computational molecular modeling with protein docking. We interviewed Washburn to find out more.
Read More
Finding the Best Cells for Faster Drug Discovery
Industry InsightAdvances in developing cell-based therapeutics and products require time-consuming and laborious cell-by-cell manipulation and analysis. Berkeley Lights Inc provide research and development services to help accelerate this process and make it more efficient via their proprietary technology. Technology Networks recently spoke with Mark White, Sr. Director of Marketing, Berkeley Lights Inc to find out more.
Read More
Developing the World's First Single Molecule Protein Sequencer
Industry InsightJagannath Swaminathan is the co-founder of Erisyon and a researcher at the Marcotte Lab at the University of Texas Austin. In this interview, we discuss the concept of next-generation protein sequencing, clinical proteomics and the critical role of protein sequencing in the fight against COVID-19.
Read More
Lung Model Aids SARS-CoV-2 Research
Industry InsightAn in vitro model of the human lung airway epithelium developed by Newcells Biotech is currently being tested as a platform for modeling SARS-CoV-2 infection. To learn more about the model and how it could help in the fight against SARS-CoV-2, Technology Networks spoke to Dr Mike Nicholds, CEO, Newcells Biotech.
Read More
Using Bioprinted Tissue Models To Test Drugs Against Diseases Including COVID-19
Industry InsightTechnology Networks recently had the pleasure of speaking with Keith Murphy, CEO and founder of Viscient Biosciences to learn about the company's expertise in 3D disease models and multi-omics drug discovery approaches, and how they are using these techniques to test drugs against SARS-CoV-2 using bioprinted lung tissue.
Read More
